Drug-induced agranulocytosis

Drug and Therapeutics Bulletin

Volumn 35, Issue 7, 1997, Pages 49-52

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; ANTITHYROID AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NEUROLEPTIC AGENT;

AGRANULOCYTOSIS; HUMAN; SHORT SURVEY;

EID: 0030670870     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.1997.35749     Document Type: Short Survey

References (26)

1. Kaufman DW, Kelly JP, Levy M, Shapiro S. The drug etiology of agranulocytosis and aplastic anemia. Oxford: Oxford University Press, 1991; 148-58.
2. Julia A, Olona M, Bueno J et al. Drug-induced agranulocytosis: prognostic factors in a series of 168 episodes. Br J Haematol 1991; 79: 366-71.
3. Vincent PC. Drug-induced aplastic anaemia and agranulocytosis. Incidence and mechanisms. Drugs 1986; 31: 52-63.
4. Heimpel H. Drug-induced agranulocytosis. Med Toxicol 1988; 3: 449-62.
5. Pisciotta AV. Immune and toxic mechanisms in drug-induced agranulocytosis. Semin Hematol 1973; 10: 279-310.
6. International Agranulocytosis and Aplastic Anaemia Study. Risk of agranulocytosis and aplastic anaemia in relation to use of antithyroid drugs. BMJ 1988; 297: 262-5.
7. Cooper DS. Antithyroid drugs. N Engl J Med 1984; 311: 1353-62.
8. Tajiri J, Noguchi S, Murakami T, Murakami N. Antithyroid druginduced agranulocytosis. The usefulness of routine white blood cell count monitoring. Arch Intern Med 1990; 150: 621-4.
9. Ruvidić R, Jelić S. Haematological aspects of drug-induced agranulocytosis. Scand J Haemat 1972; 9: 18-27.
10. Sprikkelman A, de Wolf JTM, Vellenga E. The application of haematopoietic growth factors in drug-induced agranulocytosis: a review of 70 cases. Leukemia 1994; 8: 2031-6.
11. Co-trimoxazole use restricted. DTB 1995; 33: 92-3
12. McGhee CNJ, Anastas CN. Widespread ocular use of topical chloramphenicol: is there justifiable concern regarding idiosyncratic aplastic anaemia? Br J Ophthalmol 1996; 80: 182-4
13. Atkin K, Kendall F, Gould D, Freeman H, Lieberman J, O'Sullivan D. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Br J Psychiatry 1996; 169: 483-8.
14. Keisu M, Ekman E. Sulfasalazine associated agranulocytosis in Sweden 1972-1989. Eur J Clin Pharmacol 1992; 43: 215-8.
15. Slow-acting antirheumatic drugs. DTB 1993; 31: 17-20.
16. Cooper RA. Captopril-associated neutropenia. Who is at risk? Arch Intern Med 1983; 143: 659-60.
17. Hughes WT, Armstrong D, Bodey GP et al. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 1990; 161:381-96.
18. Bodey GP. Empirical antibiotic therapy for fever in neutropenic patients. Clin Infect Dis 1993; 17 (suppl 2). S378-84.
19. de Lalla F. Antibiotic treatment of febrile episodes in neutropenic cancer patients. Clinical and economic considerations. Drugs 1997; 53: 789-804.
20. EORTC International Antimicrobial Therapy Cooperative Group. Empiric antifungal therapy in febrile granulocytopenic patients Amer J Med 1989; 86: 668-72.
21. Working Party of the British Society for Antimicrobial Chemotherapy. Working party report. Chemoprophylaxis for candidosis and aspergillosis in neutropenia and transplantation: a review and recommendations. J Antimicrob Chemother 1993; 32: 5-21.
22. Teitelbaum AH, Bell AJ, Brown SL. Filgrastim (r-metHuG-CSF) reversal of drug-induced agranulocytosis. Am J Med 1993; 95: 245-6.
23. Tamai H, Mukuta T, Matsubayashi S et al. Treatment of methimazole induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhG-CSF). J Clin Endocrinol Metab 1993; 77: 1356-60.
24. Gerson SL, Gullion G, Yeh H-S, Masor C. Granulocyte colonystimulating factor for clozapine-induced agranulocytosis. Lancet 1992, 340: 1097 [letter].
25. Anderlini P, Przepiorka D, Champlin R, Körbling M. Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood 1996; 88: 2819-25.
26. Avilés A, Guzmán R, García EL, Talavera A, Díaz-Maqueo JC. Results of a randomized trial of granulocyte colony-stimulating factor in patients with infection and severe granulocytopenia. Anticancer Drugs 1996; 7: 392-7